NeuroGeneces Inc
NeuroGeneces measures and improves your brain health.
- Stage Prototype Ready
- Industry Healthcare Services
- Location Santa Fe, NM, USA
- Currency USD
- Founded June 2021
- Employees 7
- Incorporation Type C-corp
- Website neurogeneces.com
Company Summary
NeuroGeneces’ patented technology uses AI-driven, home-based sleep test to measure your Brain Age. It identifies lifestyle factors that most affect brain health and provides clear, action steps to improve it. Knowing your Brain Age motivates changes that can reduce neurodegeneration risk by up to 50%.
Funded by NIH, NSF, and DoD, NeuroGeneces holds 2 granted and 4 pending patents, with research partners at UCSF, UNM, and the University of Miami.
Team
-
Co-Founder and CEOA former management consultant and Google executive, Karen’s passion for assessing Brain Health through sleep science stems from personal experience: her mother had Alzheimer’s and her son has a sleep disorder. A three-time patent-owner and Google Founders' Award recipient, she has a successful track record of conceptualizing innovative solutions and turning them into reality.
-
Co-Founder, Chief Science OfficerJason brings a wealth of research, clinical, and neuroscience expertise to the team. He is a neuro-psychiatrist, recognized expert in neuro-stimulation science and holds a patent in neuromodulation. He was the first Executive Director of the Research Coalition of the Central Texas Veteran Health Care System. Jason directs the company’s research and clinical trials to develop and validate NeuroGeneces’ translational technology.
-
Chief Technology OfficerAn Electrical Engineer and Computer Scientist by training, Michael has practical experience addressing software, hardware, and electrical design issues at both the technical and systems level. Later in his career, his focus as been on data science / AI where he managed diverse analytical/AI teams at Google, Facebook, and Zynga. For the past 5 years, he's led NeuroGeneces' hardware and AI development.
-
OperationsChristine oversees the daily operations of the firm, drives FDA and other regulatory strategy, oversees grant operations and compliance. As a former healthcare and corporate attorney, she counseled investor-owned and nonprofit hospital and medical systems, pharmaceutical companies, insurance providers, and private equity and venture capital firms in transactional, regulatory and governance matters.
-
Senior Software DeveloperJackson is an experienced neurotechnology engineer specializing in machine learning, neuromodulation, and biosensor data processing. Formerly with Blackrock NeuroTech, he has developed expertise in neural signal pipelines, feature extraction, and cloud-based data architecture supporting next-generation neurotech wearables and neurostimulation systems.
Advisors
-
Paul ButlerUnconfirmed
Previous Investors
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.